Results 121 to 130 of about 3,148 (231)

ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia? [PDF]

, 2016
Gerald F. Watts, Claudia Stefanutti
openalex   +1 more source

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19. [PDF]

J Clin Lipidol, 2021
Vuorio A, Raal F, Klingel R, Kovanen PT.
europepmc   +1 more source

Evaluation of Albumin Loss During Low-density Lipoprotein Apheresis

, 1990
Shunichi Kojima, Mariko Shiba, Shuichi Nomura, Genjiro Kimura, Motoo Tsushima, Morio Kuramochi, Akira Yamamoto, Ttruo Omai   +7 more
openalex   +1 more source

Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual

Journal of the International AIDS Society, Volume 27, Issue S6, November 2024.
wiley   +1 more source

A case of nephrotic syndrome due to IgA nephropathy complicated by acute renal failure and ameriolated by low density lipoprotein(LDL) apheresis.

, 1994
Tetsuo Shibata, Eiji Okabe, Akihiro Sumie, Takanori Ishii, Tadashi Tomo, Ryokichi Yasumori, Masaru Nasu, Yoshio Nomura   +7 more
openalex   +2 more sources

Dysregulation of the CD4 + T cells lineage differentiation in dyslipidemic patients and impact of lipoprotein-apheresis treatment: A case study [PDF]

, 2017
J. Papin, Ana Brennand, Giuseppina Arbore, Bernd Hohenstein, Virginia Kamvissi, Claudia Kemper, Stefan R. Bornstein   +6 more
openalex   +1 more source

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey. [PDF]

Orphanet J Rare Dis, 2021
D'Erasmo L, Gallo A, Cefalù AB, Di Costanzo A, Saheb S, Giammanco A, Averna M, Buonaiuto A, Iannuzzo G, Fortunato G, Puja A, Montalcini T, Pavanello C, Calabresi L, Vigna GB, Bucci M, Bonomo K, Nota F, Sampietro T, Sbrana F, Suppressa P, Sabbà C, Fimiani F, Cesaro A, Calabrò P, Palmisano S, D'Addato S, Pisciotta L, Bertolini S, Bittar R, Kalmykova O, Béliard S, Carrié A, Arca M, Bruckert E.   +34 more
europepmc   +1 more source

Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome

, 1999
Eri Muso, Masatoshi Mune, Yasuhiro Fujii, Enyu Imai, Naohiko Ueda, Kazuhiro Hatta, Akio Imada, Shozo Miki, Takashi Kuwahara, Yoshihiro Takamitsu, Tsukasa Takemura, Yoshiharu Tsubakihara   +11 more
openalex   +1 more source

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection

Medical Devices: Evidence and Research, 2016
Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany Abstract: This review reports the current situation ...
Julius U
doaj  

Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. [PDF]

CEN Case Rep, 2022
Nishizawa K, Yamashita T, Ogawa Y, Kobayashi H.   +3 more
europepmc   +1 more source